Publicaciones en las que colabora con Andrea Bernabeu García (20)

2024

  1. Enhancing predictive models for egg donation: time to blastocyst hatching and machine learning insights

    Reproductive Biology and Endocrinology, Vol. 22, Núm. 1

  2. Factors affecting biochemical pregnancy loss (BPL) in preimplantation genetic testing for aneuploidy (PGT-A) cycles: machine learning-assisted identification

    Reproductive Biology and Endocrinology, Vol. 22, Núm. 1

  3. Impact of Group vs Individual Embryo Culture Strategies on Blastocyst and Clinical Outcomes

    Reproductive Sciences, Vol. 31, Núm. 6, pp. 1705-1711

  4. Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: Double ovarian stimulation is beneficial independently of the genotype at position 680 of the follicle-stimulating hormone receptor

    Pharmacogenetics and Genomics, Vol. 34, Núm. 1, pp. 1-7

  5. Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial

    Frontiers in Endocrinology, Vol. 15

  6. Perinatal and postnatal outcomes up to the third year of life after the transfer of mosaic embryos compared with euploid embryos

    Fertility and Sterility

  7. Random-start ovarian stimulation in an oocyte donation programme: a large, single-centre, experience

    Reproductive BioMedicine Online, Vol. 48, Núm. 1

  8. The impact of (very) young donor age on euploid rates: An analysis of 1831 trophectoderm biopsies evaluated with 24-chromosome NGS screening in oocyte donation cycles

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 297, pp. 59-64

2023

  1. Conventional follicular-phase ovarian stimulation vs. luteal-phase stimulation in suboptimal responders: a randomized controlled trial

    F and S Reports, Vol. 4, Núm. 4, pp. 344-352

  2. Does mRNA COVID-19 vaccination in oocyte donors impact ovarian stimulation parameters or IVF outcomes for recipients?

    Reproductive BioMedicine Online, Vol. 46, Núm. 4, pp. 697-704

  3. Factors associated with embryo mosaicism: a systematic review and meta-analysis

    Journal of Assisted Reproduction and Genetics, Vol. 40, Núm. 10, pp. 2317-2324

2022

  1. Application of Machine Learning to Predict Aneuploidy and Mosaicism in Embryos From In Vitro Fertilization Cycles

    AJOG Global Reports, Vol. 2, Núm. 4

  2. Comparison of the assisted reproductive technology outcomes between conventional IVF and ICSI with donor oocytes in normozoospermic patients

    Human Fertility, Vol. 25, Núm. 1, pp. 56-62

  3. Identification of new variants and candidate genes in women with familial premature ovarian insufficiency using whole-exome sequencing

    Journal of Assisted Reproduction and Genetics, Vol. 39, Núm. 11, pp. 2595-2605

  4. Vitrification does not affect birth weight: lessons from the oocyte donation model

    Reproductive BioMedicine Online, Vol. 45, Núm. 2, pp. 355-363

2021

  1. Consistent results of non-invasive PGT-A of human embryos using two different techniques for chromosomal analysis

    Reproductive BioMedicine Online, Vol. 42, Núm. 3, pp. 555-563

  2. Expert consensus for primary management of reproductive health: a Delphi study

    Irish Journal of Medical Science, Vol. 190, Núm. 2, pp. 677-684

  3. Impact of the vaginal and endometrial microbiome pattern on assisted reproduction outcomes

    Journal of Clinical Medicine, Vol. 10, Núm. 18

2020

  1. Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: Results of a randomized controlled trial

    Reproductive Biology and Endocrinology, Vol. 18, Núm. 1

2019

  1. Effect of the vaginal microbiome on the pregnancy rate in women receiving assisted reproductive treatment

    Journal of Assisted Reproduction and Genetics, Vol. 36, Núm. 10, pp. 2111-2119